Scientists test 'Living Drug' to reset the immune system in devastating autoimmune conditions
Disease control
Ongoing
This early-stage study is testing the safety and initial effects of a personalized cell therapy called KYV-101 in adults with severe autoimmune diseases. The therapy involves collecting a patient's own immune cells, modifying them to target harmful B cells, and reinfusing them. U…
Phase: PHASE1 • Sponsor: David Porter • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC